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Introduction
Osteogenesis imperfecta (OI) comprises a heterogeneous group of inherited disorders characterized by bone fragility that is associated with other connective tissue abnormalities. Most individuals with OI have mutations that affect the structure of genes encoding the ␣ chains of type I collagen. [1] [2] [3] [4] About 1/10 000 individuals in the United States is affected by OI. 5, 6 No cure for OI exists at present. The feasibility of applying gene therapy or somatic cell therapy methodologies to cure some forms of OI is currently being investigated. [7] [8] [9] [10] [11] A mouse model of human OI has recently been described. The mouse has a spontaneous mutation that generates phenotypic and biochemical features similar to those seen in moderate to severe forms of human OI. the COL1A2 gene. 12 These mice exhibit cortical thinning, bowing of long bones, fractures and callus formation characteristic of human OI type III. This mouse provides an excellent model for investigating the potential of somatic cell therapy or gene therapy for some recessive mild forms of OI or other bone-related diseases such as osteoporosis.
Ex vivo gene therapy requires the use of cells that would act as vehicles to deliver genes of interest to bone. 13, 14 Osteoblasts are the major cells of bone that synthesize the bulk of the bone extracellular matrix, but they are terminally differentiated and nonproliferating. However, bone marrow has long been recognized as a source of osteoprogenitor cells. [15] [16] [17] [18] [19] [20] Bone marrow contains cells that can differentiate into osteoblast, chondrocytes, fibroblasts, adipocytes and myoblasts. 19, 21, 22 We previously reported that bone marrow stromal cells isolated from oim mice exhibit alkaline phosphatase activity and synthesize osteocalcin when treated with recombinant human bone morphogenetic protein (rhBMP-2). 23 The cells also mineralized the extracellular matrix in the presence of ␤-glycerophosphate and ascorbic acid. The oim stromal cells were also shown to be susceptible to gene transduction with retroviral and adenoviral vectors. These properties suggest that they may be useful in the ex vivo gene therapy of certain disorders of bone.
In the present study, we investigated the potential of the long-term cultured bone marrow stromal cells from oim mouse to form bone in vivo and cartilage in vitro and in vivo, and the homing pattern of the cells when reinfused into oim mice. The formation of bone and cartilage was assayed by seeding LacZ-positive cells into ceramic cubes that were implanted subcutaneously in nude mice. The homing pattern was determined by following the expression of the lacZ gene in mice following intravenous infusion of the LacZ-positive cells. We report here that the long-term cultured bone marrow stromal cells from oim mice expressing the lacZ gene form bone and cartilage in vitro and in vivo. The cells also persist in bone and appear to differentiate into osteoblasts in vivo.
Results

Stromal cell transduction and osteogenic potential
The bone marrow stromal cells harvested from oim mice exhibited alkaline phosphatase activity and synthesized osteocalcin in the presence of rhBMP-2 as described previously. 23 A bone marrow stromal cell line from the oim mouse that exhibited osteoblast phenotype when treated with rhBMP-2 was maintained in culture with passaging. At passage 21, the cells still exhibited the osteoblastic phenotype when treated with recombinant human bone morphogenetic protein (rhBMP-2). At this passage the cells were transduced with a retrovirus BAG lacZ neo r . This is a replication defective virus which contains the lacZ gene under the control of the retroviral 5Ј LTR and the neo r gene under the control of the SV40 early promotor ( Figure 1a ). After selection in G418, over 80% of the cells expressed the lacZ gene (Figure 1b) .
Alkaline phosphatase activity of the transduced cells Osteoprogenitor cells express osteoblast phenotype such as alkaline phosphatase activity and osteocalcin synthesis when they are treated with factors that induce osteoblast differentiation. Among the factors that induce osteoblast differentiation are glucocoticoids, 24, 25 bone morphogenetic proteins 23, 26, 27 and bFGF. 28 The transduced cells exhibited low alkaline phosphatase activity under basal conditions, rhBMP-2 treatment greatly enhanced alkaline phosphatase activity (Figure 2 ). These data indicate that the transduced cells retained osteogenic potential. The cells have been maintained in culture with passaging for over 2 years without loss of lacZ gene expression.
In vitro chondrogenesis by the transduced stromal cells Bone marrow stromal cells are pluripotent, the cells can differentiate into fibroblasts, chondrocytes, adipocytes and osteoblasts. 21 The transduced cells were assayed for chondrogenic potential in aggregate cultures to determine if the cells retained potential to differentiate into different cell types. In this assay system, cells are pelleted and suspended in a defined medium containing TGF␤ and dexamethasone, and then cultured for 21 days. Within 24 h of culture, the cells form a free-floating aggregate. After 21 days in culture the LacZ-positive cells formed an aggregate of cells that had undergone chondrogenic differentiation as indicated by the presence of chondrocytes in metachromatic matrix ( Figure 3 ). These data indicated that the transduced cells had the potential to differentiate into chondrocytes.
In vivo chondrogenesis and osteogenesis of LacZpositive cells To determine the potential of the long-term cultured bone marrow stromal cells to form cartilage and bone in vivo, the LacZ-positive cells of the 32nd passage were seeded into ceramic cubes and the cubes were implanted on to the backs of nude mice. When the cubes were recovered after 3 weeks, cartilage tissue was evident in all the cubes that were implanted as indicated by the presence of chondrocytes sorrounded by a metachromatically staining matrix (Figure 4a ). Six weeks after implantation, the cells formed bone in all the ceramic cubes implanted with the LacZ-positive cells (Figure 4b ). Osteoblast-like cells were present on the edges of the newly formed bone and some of the cells were present in bone lacunae suggesting the presence of osteocytes. This experiment was repeated with LacZ-positive cells of the 33rd passage to demonstrate that these characteristics were not confined to cells of the 32nd passage. Examination of the ceramic cubes that were seeded with the LacZ-positive cells 6 weeks after implantation, demonstrated the presence of bone in the cubes just as was seen for the cubes seeded with the 32rd passage cells (data not shown). Control ceramic cubes implanted without cells did not contain any bone (Figure 4c ). These data clearly demonstrated that the bone marrow stromal cells from oim mice form bone in vivo.
X-gal staining to demonstrate the presence of LacZpositive cells in ceramic cubes X-gal staining of all the ceramic cubes seeded with the LacZ-positive cells and recovered 6 weeks after implantation demonstrated the presence of LacZ-positive cells on the edges of the newly formed bone and in the lacunae of the bone ( Figure 5 ). The lining cells were osteoblasts and the cells in the lacunae appeared to be osteocytes. Ceramic cubes implanted without cells did not show any cells that stained with X-gal (data not shown). These data clearly demonstrate that the LacZ-positive cells seeded into the ceramic cubes differentiate into osteoblasts and osteocytes and that during this transition gene expression of the inserted gene is maintained. The data also demonstrate that cells transduced with the retrovirus retain the ability to form bone.
Homing of transduced cells
The homing pattern of the transduced cells in oim mice was assessed by following the lacZ gene expression and the presence of the viral DNA in different tissues of the recipient mice. LacZ gene expression was detected by Xgal staining and the presence of the viral DNA was determined by PCR using specific primers that cover portions of the virus and lacZ gene sequences. The cells were tracked for 4, 10, 20, 30 and 40 days after intramedullarly injection. Histological examination of the injected mice femurs 4 days following intramedullarly injection indicated the presence of LacZ-positive cells in the marrow cavity of all the injected femurs, predominantly in the primary spongiosa adjacent to the growth plate ( Figure  6a ). At 30 days after intramedullarly injection, LacZ-positive cells were observed in the marrow cavity of the injected femurs, again around the growth plate, but more LacZ-positive cells were distributed along the surface of the trabecular bone (Figure 6b ).
To assess whether the transplanted cells populated other bones of the recipient mice, contralateral femurs of each of the recipient mice were also examined for the presence of LacZ-positive cells. Histological examination of the femurs 4 days after injection, demonstrated the presence of LacZ-positive cells in the marrow cavity adjacent to the growth plate in all the contralateral femurs of the recipient mice (Figure 6c ). At 30 days after injection LacZ-positive cells were still present in marrow but most of the cells were distributed along the surface of the trabecular bone. This pattern of cell distribution was similar to the distribution of the cells in the injected femurs of the same mice (Figure 6d ). Mice injected with nontransduced cells showed only background staining probably due to endogenous ␤-galactosidase produced by osteoclasts (Figure 6e ). Histological examination of lung and liver of the mice that were injected with LacZpositive cells revealed the presence of LacZ-positive cells in these tissues 4 and 10 days after injection but not at later time-points (see below). These data demonstrate that bone marrow stromal cells have the potential to traffic through the circulatory system but that they only persist in bone.
Polymerase chain reaction PCR was used to confirm the presence of viral DNA in the femurs, liver and lung of the mice that received LacZpositive cells. PCR amplification showed a positive signal of the expected size from the injected femurs and contralateral femurs at 4, 10, 20, 30 and 40 days after injection (Figure 7a and b) . A PCR signal of the expected size was also detected in the lung and liver of the mice that received the tranduced cells at 4 and 10 days after injection but not at later time-points (Figure 7c and d) . These data support the lacZ staining results and suggest that the long-term cultured bone marrow stromal cells persist in bone but are cleared from the liver and lung by day 10, indicating that these cells have the potential to home to bone. Analysis of spleen and cartilage by PCR from the mice that recieved the transduced cells did not show any presence of LacZ-positive cells in these tissues.
Discussion
Gene therapy or somatic cell therapy may offer new treatment options for some forms of OI especially mild forms that do not involve dominant negative mutations. The results here have demonstrated that bone marrow stromal cells from a mouse model of osteogenesis imperfecta (oim) have the potential to home to bone and to form bone in vivo. The cells were easily transduced with a retrovirus carrying the lacZ and neo r genes and the genes were expressed at high efficiency both in vitro and in vivo. The cells have been maintained in culture for more than 2 years without loss of lacZ gene expression.
Porous calcium phosphate ceramics are used to evaluate the potential of certain cells for osteogenic potential. 24, 29 The ceramics are composed of ions that are similar to bone mineral and are therefore osteoconductive. 25 When cells are introduced into the ceramic cubes, bone forms on the walls of the pores of the ceramics. 24 The bone that is formed in ceramics probably arises through the intramembranous osification, ie without the cartilage intermediate. The bone marrow stromal cells are however pluripotent, they can differentiate into either chondrocytes or osteoblasts depending on the local enviromental factors. The results of the ceramic cube assay and the aggregate cultures showed that the long-term cultured bone marrow stromal cultures contained osteochondral progenitor cells. The LacZ-positive cells formed cartilage in aggregate cultures and also in ceramic cubes at 3 weeks after transplantation. At 6 weeks after transplantation the cells formed bone in ceramic cubes. The osteochondral potential of the cells was maintained after retroviral transduction, and gene expression persisted at high levels after differentiation of the cells.
X-gal staining of the ceramic cubes seeded with the oim LacZ-positive cells at 6 weeks after implantation demonstrated that bone marrow stromal cells differentiated into osteoblasts as well as into osteocytes. These data agree with a recent report by Allay et al 30 who showed that human mesechymal progenitor cells obtained from normal individuals and expressing the lacZ gene formed bone in ceramic cubes and that the cells differentiate into osteoblasts and osteocytes. The cells used in their study were, however, of the first or second passage. The present findings have shown that long-term cultured bone marrow stromal cells retrovirally transduced with the lacZ and neo r genes were efficient in forming bone and cartilage in vivo. Moreover, they show that osteoprogenitor cells obtained from animals with OI have not lost this ability as a result of their genetic abnormality. Interestingly, the LacZ-positive cells were more efficient in forming bone than nontransduced cells.
Positive X-gal staining and PCR detection of the transduced gene demonstrated that bone marrow stromal cells, when re-infused in syngeneic recipient mice persist in bone. The cells were detected in the injected femurs and contralateral femurs of the same mice. The cells were also identified in the liver and lung of the same mice but only at 10 days following injection, after which time they were cleared. These data suggest that the bone marrow stromal cells have the potential to circulate. Prockop and co-workers 7 injected freshly harvested adherent marrow cells from a transgenic mouse that expresses human mini-gene for pro␣1(I) chain into normal irradiated recipient mice to determine their homing pattern. These investigators also showed that the cells expressing the mini-gene populated several different organs of the recipient mice including cartilage at 30 days after infusion. 7 The present findings have also demonstrated that the LacZ-positive cells, injected intramedullarly into the oim mice, entered the circulatory system and transiently populated the lungs and liver of the recipient mice but only persisted in bone. By PCR analysis we could not detect any of the LacZ-positive cells in cartilage. The difference in the homing pattern between the long-term cultured cells studied here and those described by Prockop and co-workers may be due to the differences in cell populations. The long-term cultured cells in our culture system may contain more osteoprogenitor cells or the cells may have been at a different stage of differentiation. Nevertheless, our present data agree with their findings in that the bone marrow stromal cells have the potential to circulate. This is important because treatment of OI will require wide-spread dissemination of corrective cells.
The homing pattern of the transduced cells was
Figure 4 Osteochondrogenesis of the transduced cells in vivo. LacZ-positive cells were seeded in ceramic cubes and the cubes were subcutaneously implanted in nude mice. (a) Three weeks after implantation, the cells formed cartilage and (b) at 6 weeks after implantation the cells formed bone (B). (c) Ceramic cubes implanted without cells did not induce cartilage or (d) bone. (a) and (c) sections were stained in toluidine blue and in (b) and (d)
were stained with Mallory-Heidenehain. Original magnification × 200.
Figure 5 X-gal staining of the ceramic cubes seeded with the LacZ-positive cells. Ceramic cubes seeded with the LacZ-positive cells and implanted in nude mice were harvested 6 weeks after implantation and stained with X-gal, sectioned and counterstained lightly with fast red. LacZ-positive cells are along the edges of the newly formed bone indicating the presence of osteoblasts (OS) and some cells are in the lacunae of the newly formed bone suggesting the presence of osteocytes (OC). Original magnification × 200.
Figure 6 Histological sections of the oim mice femurs that received the transduced cells. Bone marrow stromal cells transduced with BAG-lacZ neo r were injected intramedullarly into oim mice femurs and the femurs were harvested at 4, 10, 20, 30 and 40 days after injection. (a) Four days after injection, LacZ-positive cells are located in the marrow cavity of the injected femurs adjacent to the growth plate. (b) Thirty days after injection LacZpositive cells are seen in the marrow, but some are also present on the edges of the trabecular bone (arrow heads). (c) Contralateral femurs show similar cell distribution, at 4 days after injection and (d) 30 days after injection. (e) Histological section of a femur injected with nontransduced cells shows only background staining probably due to the indogenously produced ␤-galactosidase by osteoclasts. The data suggest that the cells may differentiate into osteoblasts in vivo and that they also have the potential to traffic through the circulatory system. Original magnification ×100.
followed in the bone by X-gal staining. When the LacZpositive cells were infused in mice, 4 days after injection, X-gal staining showed that the LacZ-positive cells were mostly in the marrow cavity of both the injected femurs and contralateral femurs. By 30 days after injection, most of the LacZ-positive cells were distributed along the surface of the trabecular bone. These data suggest that the infused cells that persist in bone may differentiate into osteoblasts in vivo. It is interesting to note, that although there was cell engraftment in the bones of the recipient mice, the mice were not initially conditioned by irradiation or by chemical treatment. These data suggest that cell engraftment can be achieved without prior marrow ablation. The present findings have shown that the long-term cultured bone marrow stromal cells isolated from a mouse model of human OI home to bone, form bone and continue to express exogenous genes. These findings open the possibility for the use of these cells as vehicles to deliver normal genes to bone as an alternative approach for the treatment of some forms of OI. Although dominant negative mutations are a challenge for gene or cell therapy, if the elimination or silencing of the mutant gene becomes possible then bone marrow stromal cells could be used therapeutically in the manner indicated by this work. Although much further research remains to be done, the present findings offer an excellent opportunity to investigate the feasibility of this idea with this mouse model of human OI.
Materials and methods
All tissue culture reagents were purchased from GIBCO BRL (Grand Island, NY, USA), G418 (geneticin) was from Calbiochem (La Jolla, CA, USA). All other reagents were from Sigma (Sigma Chemical Co, St Louis, MO, USA). Osteogenesis imperfecta mice were obtained from Jackson Laboratories (Bar Harbor, ME, USA). Recombinant human bone morphogenetic protein-2 was kindly provided by Genetics Institute (Cambridge, MA, USA).
Cell isolation and culture procedure Bone marrow was harvested from oim mice by flushing marrow from the femurs and tibias with Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 1% penicillin/streptomycin, and 1% l-glutamine, as previously described. 23 Cells were passed through a 21-gauge needle several times and washed by centrifugation in Geys balanced salt solution (GBSS). The cells were then seeded into T-75 flasks at 37°C in 5% CO 2 and allowed to adhere to the flasks without disturbance for 7 days. All non-adherent cells were then removed and the medium was changed every 3 days thereafter. The adherent cells (representing bone marrow stromal cells) were trypsinized and passaged weekly with a 1:4 split. The established cells were assessed for osteogenic potential by determining the osteoblast phenotype after treatment with human recombinant bone morphogenetic protein (rhBMP-2). 23 Transduction of bone marrow stromal cells with BAGLacZ neo r At passage 21, the cells were grown to 60% confluence in T-75 flasks, medium was removed, and the cells were transduced by adding 4 ml of supernatant Crip-BAG producer cell containing106 c.f.u./ml of the BAG retroviral vector in the presence of 8 g/ml of polybrene for 24 h. The BAG retroviral vector expresses the lacZ marker gene from the viral LTR and the neo r gene from an internal SV40 promoter. 31 After transduction, the medium containing the viral suspension was removed and replaced with the regular medium and the cells were incubated further in T-75 flasks for 72 h. Cells were then transferred to DMEM containing G418 (0.5 mg/ml) to select for neomycin-resistant cells. To check the efficiency of transduction, an aliquot of the transduced cells was replated in a 35-mm petri dish and stained with X-gal (5-bromo-4-chloroindolyl-␤-d-galactosidase).
Determination of alkaline phosphatase activity Alkaline phosphatase activity was determined as described previously. 23 Briefly, bone marrow stromal cells were cultured in 24-well plates in the presence of rhBMP-2 (100 ng/ml) with medium changes every 2 days for 6 days. On day 7, cells were washed with GBSS and lysed by three freeze-thaw cycles. Aliquots of the lysates were used for the alkaline phosphatase assay using the Sigma alkaline phosphatase activity assay kit. The experiment was performed in triplicate and was performed also on passaged cells.
In vitro chrondrogenesis of LacZ-positive cells
To determine whether LacZ-positive cells isolated from oim mouse had chondrogenic potential, aggregate culture assays were performed. The method used is as described previously 32 and was modified from the methods described previously for the growth plate chondrocytes. 33, 34 Briefly, three different aliquots of 2 × 10 5 LacZpositive cells at passage 32 and 33 in DMEM were separately placed in 15 ml polypropylene conical tubes. The cells were centrifuged at 500 g and the FBS containing medium was replaced with a defined medium, consisting of DMEM with insulin (6.25 mg/ml), transferrin (96.25 mg/ml) selenious acid (6.25 mg/ml), bovine serum albumin (1.25 mg/ml), linoleic acid (5.35 mg/ml), pyruvate (1 mm), ascorbate 2-phosphate (50 ng/ml) and dexamethasone 10− 7 m and TGF-␤1 (10 ng/ml). The cells were incubated at 37°C in 5% CO 2 . Medium changes were carried out every 2 days and the pellets were harvested at 21 days. The aggregates were frozen in OCT and 5 m sections were cut and stained with toluidine blue.
Assay for bone and cartilage formation in ceramic cubes At passage 32 and 33, the LacZ-positive cells were seeded separately into two 3 mm 3 cubes of tricalcium phosphate/hydroxyapatite composite ceramic with pores 200-400 m (Zimmer Orthopaedic, Warsaw, IN, USA). The cubes were sterilized and then fibronectin coated by soaking in fibronectin solution (1 mg/ml) followed by drying under a hood overnight. 29 The cells were loaded into the cubes by placing them into the cell suspension (5 × 10 6 cells/ml in serum-free medium); a vacuum was applied to remove the air bubbles and to allow the cells access to all the cube pores. 29 The ceramic cubes were then incubated at 37°C in a CO 2 incubator for 2 h to allow the cells to attach. They were then implanted subcutaneously on to the backs of nude mice which were killed at 3 and 6 weeks after implantation. The ceramic cubes were fixed in 10% neutral buffered formalin and processed for histology. Tissue sections were either stained with Mallory-Heidenhain or toluidine blue. Each stained section was examined and scored for bone formation as described previously. 29, 35 X-gal staining of ceramic cubes for LacZ-positive cells To determine whether the transduced cells formed bone in ceramic cubes, the cubes were seeded with the LacZpositive cells and the ceramic cubes were implanted onto the backs of the nude mice. The cubes were harvested at 6 weeks after implantation, fixed and stained with Xgal. For X-gal staining, the ceramic cubes were rinsed three times in LacZ rinse buffer (1 mm MgCl 2 in PBS) for 30 min and then suspended in X-gal staining solution in potassium ferricynide (KC) and incubated for 24 h at 37°C in a dry oven. 36 After staining in X-gal solution, the ceramic cubes were demineralized in 20% EDTA for 3 days then post-fixed in buffered 10% formalin and paraffin embedded. Tissue sections (5 m) were cut and countstained lightly with nuclear fast red. Control cubes were implanted without cells and were processsed as above.
Stromal cell transplantation into oim mice At passage 33, the LacZ-positive cells were trypsinized, washed by centrifugation and resuspended in GBSS to a final concentration of 2 × 10 7 cells/ml. A 100-l aliquot of cell suspension (2 × 10 6 cells) was injected intramedullarly into one femur of the 8-week-old recipient oim mice.
Before injection, the mice were anesthetized, and an incision was made in the skin above the knee to expose the knee joint. Cells were injected into the femur through the condyle with a 26-gauge syringe. A total of 15 mice received the LacZ-positive cells and three mice were killed at each of the time-points, 4, 10, 20, 30 and 40 days after injection. The femurs, liver and lung were dissected from the recipient mice and examined for lacZ gene expression by X-gal staining. Control mice were injected with nontransduced cells and were killed at the same time-points as above.
Whole mount X-gal staining of the harvested organs The tissues harvested from the mice that received the LacZ-positive cells, were cleaned of adherent tissues and fixed in 4% paraformaldehyde for 24 h. The fixed tissues were rinsed three times in lacZ rinse buffer (1 mm MgCl 2 in PBS) for 30 min and then suspended in X-gal staining solution in KC and incubated for 24 h at 37°C in a dry oven. 36 After X-gal staining, soft tissues were rinsed in PBS, post-fixed in 10% buffered formalin for 24 h and paraffin embedded. For bone, after staining in X-gal solution, the tissues were demineralized in 20% EDTA for 3 days then post-fixed in buffered 10% formalin and paraffin embedded. Tissues sections (5 m) were cut and countstained lightly with eosin.
PCR DNA was isolated from the femurs, liver and lung of the mice that received the LacZ-positive cells at 4, 10, 20, 30 and 40 days after injection using a DNA Isolation Kit (Easy-DNA; Invitrogen, San Diego, CA, USA) following the manufacturer's procedures. 500 ng of genomic DNA was amplified by PCR using specific primers that span portions of BAG virus and lacZ genes. The sequence of primers were 5Ј-CAGTTCCCGCCTCCGTCTGAA-3Ј (coding sense) and 5Ј-GCACCACAGATGAAACGCCG-3Ј (anticoding sense). The predicted size of the amplified DNA fragments was 590 bases. The amplification profiles consisted of denaturation at 94°C for 1 min, annealing at 59°C for 1 min and extension at 72°C for 1 min. The amplification was repeated for 35 cycles. Amplified DNA was resolved by electrophoresis in 1.5% agarose gels and stained with ethidium bromide.
